Angela Santoni | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells. role of cMYC-IRF4-miR-125b interplay	JOURNAL OF HEMATOLOGY & ONCOLOGY	2016
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells	ONCOIMMUNOLOGY	2016
Regulation of NKG2D Expression and Signaling by Endocytosis	TRENDS IN IMMUNOLOGY	2016
NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2	IMMUNOLOGY LETTERS	2016
Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression	JOURNAL OF IMMUNOLOGY	2016
Post-transcriptional regulation of 5'-untranslated regions of human Transient Receptor Potential Vanilloid type-1 (TRPV-1) channels: role in the survival of glioma patients.	ONCOTARGET	2016
Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases.	FRONTIERS IN IMMUNOLOGY	2016
Targeting NKG2D and NKp30 ligands shedding to improve NK cell–based immunotherapy	CRITICAL REVIEWS IN IMMUNOLOGY	2016
Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice	Nature CommunicationsNATURE COMMUNICATIONS	2015
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients	ONCOIMMUNOLOGY	2015
NK cells and interferons	CYTOKINE & GROWTH FACTOR REVIEWS	2015
Multifunctional human CD56low CD16low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.	HAEMATOLOGICA	2015
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma	BIOMED RESEARCH INTERNATIONAL	2015
The multifaceted role of PIP2 in leukocyte biology	CELLULAR AND MOLECULAR LIFE SCIENCES	2015
The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma	ONCOTARGET	2015
Response to comment on multifunctional human CD56<sup>low</sup>CD16<sup>low</sup> NK cells are the prominent subset in bone marrow of both pediatric healthy donors and leukemic patients	HAEMATOLOGICA	2015
Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells	CANCER RESEARCH	2015
In Vivo Imaging of Natural Killer Cell Trafficking in Tumors	THE JOURNAL OF NUCLEAR MEDICINE	2015
The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro	JOURNAL OF IMMUNOTHERAPY	2015
Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells.	ONCOTARGET	2015